JW Life Science

JW Life Science EBIT Margin

The EBIT Margin (Operating Margin) of JW Life Science (234080.KS) as of Oct 16, 2026 is 12.89 %. In the previous year, EBIT Margin (Operating Margin) was 17.06 % — a change of -24.40% (lower).

EBIT Margin

12.89 %

YoY

-24.40%

Last updated:

EBIT Margin (Operating Margin) of JW Life Science is 2025 12.89 % . EBIT Margin (Operating Margin) of JW Life Science was 2024 17.06 % . It decreases by -24.40% lower compared to the previous year.

For JW Life Science, the operating (EBIT) margin of 12.9% is down versus 21.5% a few years ago.

The JW Life Science EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2017
16.56 KRW
Jan 1, 2018
15.17 KRW
Jan 1, 2019
17.48 KRW
Jan 1, 2020
21.50 KRW
Jan 1, 2021
16.73 KRW
Jan 1, 2022
14.34 KRW
Jan 1, 2023
17.06 KRW
Jan 1, 2025
12.89 KRW
The JW Life Science EBIT Margin history
YEAREBIT MarginYoY
12.89 %-24.40%
17.06 %+18.95%
14.34 %-14.32%
16.73 %-22.16%
21.50 %+23.00%
17.48 %+15.24%
15.17 %-8.41%
16.56 %+1.26%
16.35 %+10.39%
14.81 %+12.65%
13.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

JW Life Science Stock analysis

What does JW Life Science do? JW Life Science Corp is a South Korean pharmaceutical company headquartered in Dangjin. The company manufactures intravenous fluids including basic IV fluids with water, electrolytes, and glucose; nutrient infusion solutions containing amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions for specific medical cases. It also produces total parenteral nutrition (TPN) products. The company went public on October 27, 2016, with its stock listed on the Korea Exchange under ticker 234080.KS. Its ISIN is KR723080000. The company's website is https://www.jw-lifescience.co.kr/ JW Life Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JW Life Science stock

EBIT Margin (Operating Margin) of JW Life Science is 12.89 % in 2025.

EBIT Margin (Operating Margin) of JW Life Science changed from 17.06 % to 12.89 %, representing a -24.40% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) JW Life Science since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s JW Life Science with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — JW Life Science

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — JW Life Science